Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect [Yahoo! Finance]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance
Factors to Note The Zacks Consensus Estimate for Moderna's total revenues is pegged at around $125 million, while the same for earnings stands at a loss of $3.59 per share. Both metrics indicate significant declines from the year-ago quarter's levels. During the first quarter, sales of COVID-19 vaccines are likely to have declined due to lower demand. The Zacks Consensus Estimate for the vaccine sales is pegged at $112 million. Investors would likely be seeking updates from Moderna on its commercial launch plans for the RSV vaccine mRNA-1345, on which the FDA will announce its verdict next month. If approved, mRNA-1345 could be Moderna's second product to market, whose commercial launch is expected in the third quarter of 2024. Moderna is also working on expanding the use of mRNA-1345 in pediatric populations. Investors would also be inclined about Moderna's progress with its pipeline. The company is developing 45 mRNA-based investigational candidates in different stages of c
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at Evercore ISI to a "hold" rating.MarketBeat
- OpenAI's marketing head shares the one big mistake CMOs are making with AI [Yahoo! Finance]Yahoo! Finance
- OpenAI's marketing head shares the one big mistake CMOs are making with AI [Fortune]Fortune
- ProofPilot Celebrates Dual Wins with Moderna at Citeline Awards for Best Patient-Facing Technology & Clinical Partnership of the Year [Yahoo! Finance]Yahoo! Finance
- Moderna, Inc. (NASDAQ: MRNA) is now covered by analysts at Evercore ISI. They set an "in-line" rating and a $120.00 price target on the stock.MarketBeat
MRNA
Earnings
- 5/2/24 - Beat
MRNA
Sec Filings
- 5/15/24 - Form 144
- 5/15/24 - Form 144
- 5/13/24 - Form 4
- MRNA's page on the SEC website